About Lucida Pharmaceuticals Private Limited
Data last updated:
Lucida Pharmaceuticals Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U52609MH2018PTC307410. Its GSTIN is 27AADCL5705H1ZK (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Deepali Rajendra Kalantri and Mahesh Rameshwar Kalantri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 16 Shreya Nagar Near Kalda Corner, Aurangabad, Maharashtra, India – 431005.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.9 Lakh, a decline of 33% compared to the previous year. For the same year it recorded a net loss of ₹3.28 Lakh (net margin -55.6%) and EBITDA of -₹2.59 Lakh (EBITDA margin -44%). Revenue has declined at a compounded annual rate (CAGR) of 25% over three years and 11% over five years.
For more details, the company can be reached via its website lucidapharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No 16 Shreya Nagar Near Kalda Corner, Aurangabad, Maharashtra, India – 431005
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Lucida Pharmaceuticals Private Limited
The main business activity of Lucida Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Lucida Pharmaceuticals Private Limited FY 2025 filings available
Lucida Pharmaceuticals Private Limited reported revenue of ₹5.9 Lakh (down 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Lucida Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 11% over five years, including a 33% fall in the latest year. EBITDA fell 173% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Lucida Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹2.59 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.28 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Lucida Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -44% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -55.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Lucida Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Lucida Pharmaceuticals Private Limited
Lucida Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Riedeli Pharmaceuticals Private Limited | ₹5.95 Lakh (FY 2024) | •••• | •••• | -1.0% | •••• | Allahabad, Uttar Pradesh, India |
| Mahi Biotech Limited | ₹5.95 Lakh (FY 2025) | •••• | •••• | -67.0% | •••• | Budaun, Uttar Pradesh, India |
| Prumed Pharmaceuticals Private Limited | ₹5.94 Lakh (FY 2025) | •••• | •••• | -49.0% | •••• | Saurbazar, Bihar, India |
| Denice Pharmaceuticals Private Limited | ₹5.92 Lakh (FY 2022) | •••• | •••• | 91.0% | •••• | Jabalpur, Madhya Pradesh, India |
| Microsys Pharmaceuticals Private Limited | ₹5.9 Lakh (FY 2022) | •••• | •••• | -9.0% | •••• | Hathras, Uttar Pradesh, India |
| Lucida Pharmaceuticals Private Limited this company | ₹5.9 Lakh (FY 2025) | •••• | •••• | -33.0% | •••• | Aurangabad, Maharashtra, India |
| Gour Pharmaceuticals Private Limited | ₹5.9 Lakh (FY 2022) | •••• | •••• | 51.0% | •••• | Sehore, Madhya Pradesh, India |
| Vision Pharmatech Exports Private Limited | ₹5.88 Lakh (FY 2025) | •••• | •••• | 76.0% | •••• | Bangalore, Karnataka, India |
| Gyrus Pharmaceuticals Private Limited | ₹5.85 Lakh (FY 2025) | •••• | •••• | 21.0% | •••• | Amritsar, Punjab, India |
| Geetanjali Pharmaceuticals (India) P. Ltd. | ₹5.85 Lakh (FY 2024) | •••• | •••• | -49.0% | •••• | Thane, Maharashtra, India |
| Maclaren Pharmaceuticals Private Limited | ₹5.84 Lakh (FY 2022) | •••• | •••• | -16.0% | •••• | Bareilly, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Lucida Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Lucida Pharmaceuticals Private Limited
Lucida Pharmaceuticals Private Limited is audited by BHARTIYA SAHUJI & WAGHMARE for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BHARTIYA SAHUJI & WAGHMARE | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Lucida Pharmaceuticals Private Limited
Lucida Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepali Rajendra Kalantri | Director | 06 Jun 2018 | 8 Years 4 Months | Current |
| Mahesh Rameshwar Kalantri | Director | 03 Apr 2018 | 8 Years 6 Months | Current |
Ownership and Shareholding of Lucida Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Lucida Pharmaceuticals Private Limited
Lucida Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Lucida Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Lucida Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Lucida Pharmaceuticals Private Limited
Lucida Pharmaceuticals Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Deepali Rajendra Kalantri was appointed as Director on 06 Jun 2018.
Credit Ratings, Litigation & Regulatory Alerts for Lucida Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Lucida Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Lucida Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Lucida Pharmaceuticals Private Limited
Lucida Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCL5705H1ZK | Maharashtra | Active | 20 May 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Lucida Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lucida Pharmaceuticals Private Limited
Lucida Pharmaceuticals is an active private limited company based in Aurangabad, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 April 2018 (8+ years old) and is registered under CIN U52609MH2018PTC307410.
Lucida Pharmaceuticals reported revenue of ₹5.9 Lakh for FY 2025 (down 33% YoY).
Lucida Pharmaceuticals has 2 current directors:
- Deepali Rajendra Kalantri - Director
- Mahesh Rameshwar Kalantri - Director
Lucida Pharmaceuticals reported a net loss of ₹3.28 Lakh (net margin -55.6%) and EBITDA of -₹2.59 Lakh (EBITDA margin -44%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Lucida Pharmaceuticals is -25% over three years and -11% over five years. In the latest year (FY 2025) revenue fell 33%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Lucida Pharmaceuticals is 27AADCL5705H1ZK, registered in Maharashtra.
The CIN (Corporate Identification Number) of Lucida Pharmaceuticals is U52609MH2018PTC307410. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lucida Pharmaceuticals was incorporated on 03 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Lucida Pharmaceuticals by revenue are Riedeli Pharmaceuticals Private Limited, Mahi Biotech Limited, Prumed Pharmaceuticals Private Limited, Denice Pharmaceuticals Private Limited, Microsys Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Deepali Rajendra Kalantri was appointed as Director on 06 Jun 2018. Nisharani Nileshkumar Agrawal ceased to be Director on 06 Jun 2018. Mahesh Rameshwar Kalantri was appointed as Director on 03 Apr 2018.
Lucida Pharmaceuticals can be reached through the website lucidapharma.com. Its registered office is in Aurangabad, Maharashtra, India.